SCHEMBL20150414

SCHEMBL20150414

Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C)cc4)ccc2n3-c2ccc(C#N)cc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
ABCG2 Q9UNQ0 7/20 0.38
GABRA1 P14867 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21090881 0.97 PTGER4 (0.40) KDM4EHPGDPPARGNCOA2NCOA1
SCHEMBL20996082 0.94 ABCG2 (0.40) KDM4EABCG2GABRA1GABRA5GABRA3
SCHEMBL20114881 0.94 ABCG2 (0.40) KDM4EABCG2GABRA1GABRA5GABRA3
SCHEMBL26946726 0.94 ABCG2 (0.35) KDM4EHPGDPPARGNCOA2NCOA1
SCHEMBL21364840 0.94 ABCG2 (0.39) KDM4EHPGDPPARGNCOA2NCOA1
SCHEMBL27015799 0.94 ABCG2 (0.39) KDM4EHPGDPPARGNCOA2NCOA1
SCHEMBL24924215 0.93 ABCG2 (0.41) ABCG2GABRA1GABRA5GABRA3GABRA2
SCHEMBL20156258 0.93 ABCG2 (0.41) ABCG2GABRA1GABRA5GABRA3GABRA2
SCHEMBL22243026 0.93 CYP1A2 (0.40) KDM4EHPGDPPARGNCOA2NCOA1
SCHEMBL21090046 0.93 ABCG2 (0.37) KDM4EHPGDPPARGNCOA2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 KDM4E 2860/4885HPGD 2446/4885PPARG 4625/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 KDM4E 2860/4885HPGD 2446/4885PPARG 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.